NIBIOHN, US Biotech to Develop COVID-19 Replicon RNA Vaccine; Japan PII Eyed Next Summer

August 5, 2020
Yasuhiro Yasutomi, Director, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) will collaborate with US-based VLP Therapeutics to develop a replicon RNA vaccine against the...read more